Brain Cancer

A drug combination is showing promise in mouse models and may lead to a new treatment option for patients with glioblastoma.

Experts from the Dana-Farber Cancer Institute discuss upcoming advances in the field of brain cancer treatment and research.

While other cancers seem to occur more frequently in people with high blood sugar, that is not the case for brain cancer, according to a recent study.

There are so many ideas of what it is to be strong, but what if strength lies in being honest, being vulnerable and being ourselves?

Learn about National Brain Tumor Awareness Month, featuring clear brain tumor facts and the need for brain tumor research, from a 19-year brain tumor survivor.

Glioblastomas are difficult to treat, but researchers are hopeful that clinical trials will lead to new developments.

Malignant tumors of the brain or spinal cord represent about 1 percent of all cancers. Michael Feuerstein, Ph.D., M.P.H., is among that small percentage.

Patients with glioblastoma multiforme (GBM) saw a 37 percent reduced risk of death and increased overall survival (OS) when treated with tumor treating fields (TTFields), according to a landmark analysis of the findings from the EF-14 trial.

As researchers test new treatments for GBM, understanding the unique needs of patients with this diagnosis and their caregivers remains crucial.

A recent study found that individuals who had the chickenpox virus when they were younger were less likely to eventually develop gliomas.

Former Vice President Joe Biden is launching a cancer nonprofit to tackle some of the hard-hitting issues patients with cancer face, such as high drug prices.

BethAnn Telford recently spent a week running a marathon a day on each of the seven continents to raise money and awareness for childhood cancers. This is after her own brain cancer diagnosis more than a decade ago.

Though now used for patients with grade 4 brain tumors, tumor treating fields are being tested for use in grade 3 tumors.

Genetics can help determine a patient's risk of developing a brain tumor, as well as what treatments may work.

The World Health Organization (WHO) reclassified some types of brain cancers, giving a clearer outline on how to treat them.

Dellann Elliott Mydland, founder and president of the EndBrainCancer Initiative and 2016 GBM Hero, discusses how miracles do happen in the world of glioblastoma multiforme (GBM), and people survive.

Fran Drescher, actress, author and 16-year cancer survivor, spoke at CURE's GBM Heroes event.

The combination of onartuzumab and Avastin (bevacizumab) showed no additional benefit for patients with glioblastoma, according to a recent study.

​Gary Mervis, 2016 GBM Hero and founder of Camp Good Days and Special times, Inc., discusses the need for research in the field of glioblastoma multiforme (GBM).

Author Anna Dewdney died of brain cancer, but instead of having funeral arrangements, she asked that people spend their time reading to children.

Sumul N. Raval, M.D., founder and director of the Zocchi Brain Tumor Center at Monmouth Medical Center and 2016 GBM hero, tells his patients, "I'm your quarterback."

Icotinib greatly improved intracranial progression-free survival for patients with lung cancer who have brain metastases, according to a recent study.

In the future, entrectinib may play an increasing role in the treatment of brain tumors, as well as other cancers.

We all deal with pain. For some of us, it is chronic, but we can't give up. Pain can be a tricky partner to walk along side and is different for everyone. For me, I must face it. I must try to heal it, and I must try to take steps forward, no matter how tiny they may be.

Long-term data from the phase 3 EF-14 study showed that Optune plus temozolomide had a survival benefit compared to temozolomide alone.